Capricor Announces Positive Results from its Interim Analysis in the HOPE-2 Trial
Capricor Therapeutics has just announced positive results from their interim analysis in the HOPE-2 Trial after placing a voluntary dosing hold earlier this year. Please join PPMD and Capricor as we host a webinar Wednesday,…Learn More